Levels of fibroblast growth factor 2 in synovial fluids in human patients with internal derangement of the temporomandibular joint

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 96, Issue 6, 2003, Pages 673-679

  Sato, Jun ^a   Segami, Natsuki ^a   Kaneyama, Keiseki ^a   Konishi, Hiroaki ^a   Yoshitake, Yoshino ^a   Nishikawa, Katsuzo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTHROSCOPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT BIOPSY; JOINT DISLOCATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; SYNOVIAL FLUID LEVEL; TEMPOROMANDIBULAR JOINT DISORDER; VISUAL ANALOG SCALE;

EID: 0345734182     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.08.016     Document Type: Article

References (30)

1. Merrill R.G., Yih W.Y., Langan M.J. A histologic evaluation of the accuracy of TMJ diagnostic arthroscopy. Oral Surg Oral Med Oral Pathol. 70:1990;393-398.
2. Gynther G.W., Holmlund A.B., Reinholt F.P. Synovitis in internal derangement of the temporomandibular joint Correlation between arthroscopic and histologic findings . J Oral Maxillofac Surg. 52:1994;913-917.
3. Sato J., Segami N., Yoshitake Y., Nishikawa K. Correlation of the expression of fibroblast growth factor-2, vascular endothelial growth factor, and their receptors with angiogenesis in synovial tissues from patients with internal derangement of the temporomandibular joint. J Dent Res. 82:2003;272-277.
4. Fu K., Ma X., Zhang Z., Pang X., Chen W. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain. 9:1995;131-137.
5. Kubota E., Kubota T., Matsumoto J., Shibata T., Murakami K. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg. 56:1998;192-198.
6. Takahashi T., Kondoh T., Fukuda M., Yamazaki Y., Toyosaki T., Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 85:1998;135-141.
7. Suzuki T., Segami N., Kaneyama K., Nishimura M., Nojima T. Specific expression of interleukin-1β in temporomandibular joints with internal derangement correlation with clinical findings . Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 88:1999;413-417.
8. Segami N., Miyamaru M., Nishimura M., Suzuki T., Kaneyama K., Murakami K. Does joint effusion on T2 MRI reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 94:2002;515-521.
9. Gospodarowicz D. Fibroblast growth factor. Crit Rev Oncog. 1:1989;1-25.
10. Burgess W.H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 58:1989;575-606.
11. Qu Z., Huang X.N., Ahmadi P., Andresevic J., Planck S.R., Hart C.E., et al. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest. 73:1995;339-346.
12. Segami N., Kaneyama K., Tsurusako S., Suzuki T. Arthroscopic eminoplasty for habitual dislocation of the temporomandibular joint preliminary study . J Craniomaxillofac Surg. 27:1999;390-397.
13. Sato J., Segami N., Suzuki T., Kaneyama K., Yoshitake Y., Nishikawa K. The expression of vascular endothelial growth factor in synovial tissues in patients with internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 93:2002;251-256.
14. Murakami k, Segami N., Fujimura K., Iizuka T. Correlation between pain and synovitis in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg. 49:1991;1159-1161.
15. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabeled antibody (PAP) procedures . J Histochem Cytochem. 29:1981;577-580.
16. Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H., Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity invalidity of the antibodies for tumor angiogenesis . Proc Natl Acad Sci U S A. 86:1989;9911-9915.
17. Yoshitake Y., Nishikawa K. Distribution of fibroblast growth factors in cultured tumor cells and their transplants. In Vitro Cell Dev Biol. 28A:1992;419-428.
18. Cordon-Cardo C., Vlodavsky I., Haimovitz-Friedman A., Hicklin D., Fuks Z. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest. 63:1990;832-840.
19. Hosaka S., Shah M.R., Barquin N., Haines G.K., Koch A.E. Expression of basic fibroblast growth factor and angiogenin in arthritis. Pathobiology. 63:1995;249-256.
20. Yonezawa Y., Kondo H., Hirai R., Kaji K., Nishikawa K. Species-specific differences in the mitogenic activity of heparin-binding growth factors in the sera of various mammals. Experientia. 48:1992;239-245.
21. Hughes S.E., Hall P.A. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest. 69:1993;173-182.
22. Junquera F., Saperas E., Torres I., Vidal M.T., Malagelada J.R. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol. 94:1999;1070-1076.
23. Sato J., Segami N., Suzuki T., Yoshitake Y., Nishikawa K. The expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in chondrocytes in synovial chondromatosis of the temporomandibular joint. Report of two cases. Int J Oral Maxillofac Surg. 31:2002;532-536.
24. Ohta T., Yamamoto M., Numata M., Iseki S., Tsukioka Y., Miyashita T., et al. Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinoma. Br J Cancer. 72:1995;824-831.
25. Bussolino F., Albini A., Camussi G., Presta M., Viglietto G., Ziche M., et al. Role of soluble mediators in angiogenesis. Eur J Cancer. 32A:1996;2401-2412.
26. Mignatti P., Morimoto T., Rifkin D.B. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci U S A. 88:1991;11007-11011.
27. Mignatti P., Morimoto T., Rifkin D.B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol. 151:1992;81-93.
28. Koch A.E. Angiogenesis implications for rheumatoid arthritis . Arthritis Rheum. 41:1998;951-962.
29. Sato J., Segami N., Nishimura M., Demura N., Yoshimura H., Yoshitake Y., et al. Expression of interleukin 6 in synovial tissues in patients with internal derangement of the temporomandibular joint. Br J Oral Maxillofac Surg. 41:2003;95-101.
30. Hamerman D., Taylor S., Kirschenbaum I., Klagsbrun M., Raines E.W., Ross R., et al. Growth factors with heparin binding affinity in human synovial fluid. Proc Soc Exp Biol Med. 186:1987;384-389.